Outset Medical: BML reports 14.7% passive stake
The reported position carries shared voting and dispositive power over 2,764,610 shares, representing 14.7% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Outset Medical, Inc. is the issuer for which BML Investment Partners, L.P. reported beneficial ownership of 2,764,610 common shares, or 14.7% of the class. The partnership reported shared voting and dispositive power over 2,764,610 shares and sole voting and dispositive power over 0 shares. BML Capital Management, LLC is the partnership’s sole general partner; its managing member, Braden M. Leonard, is deemed an indirect owner of the partnership’s shares. The reporting persons disclaim that they constitute a statutory group under Rule 13d-5(b)(1).
Key Figures
Key Terms
beneficially owned regulatory
statutory group regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.